Sodium nitroprusside in patients with compromised left ventricular function undergoing coronary bypass: Reduction of cardiac proinflammatory substances
P. Massoudy et al., Sodium nitroprusside in patients with compromised left ventricular function undergoing coronary bypass: Reduction of cardiac proinflammatory substances, J THOR SURG, 119(3), 2000, pp. 566-574
Citations number
18
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Objective: The aim of the present study was to investigate whether the nitr
ic oxide donor sodium nitroprusside can reduce the cardiac inflammatory res
ponse during coronary artery bypass grafting in patients with severely comp
romised left ventricular function, Methods: Patients (n = 30) were assigned
to receive placebo or sodium nitroprusside (0.5 mu g . kg(-1) . min(-1)) f
or the first 60 minutes of reperfusion, Interleukin 6, interleukin 8, and t
umor necrosis factor alpha: levels; platelet adhesion molecule CD41 and CD6
2 levels; and CD11b on leukocytes were determined in the radial artery and
coronary sinus before cardiopulmonary bypass and during repel fusion (1, 5,
10, 35, and 75 minutes), Results: At 1 minute of reperfusion, coronary ven
ous levels of CD41-positive polymorphonuclear leukocytes were 8% lower than
arterial levels in the placebo group and 18% higher in the sodium nitropru
sside group (P =.021), At 5 minutes of reperfusion, the respective levels w
ere 29% and 1% for interleukin 6 (P =.015), -5% and 20% for CD41-positive m
onocytes (P =.032), and -2% and 16% for CD11b-positive monocytes (P =.038),
At 10 minutes of reperfusion, these levels were -14% and 21% for CD41-posi
tive monocytes (P =.006). At 35 minutes of reperfusion, these levels were -
13% and 7% for CD41-positive monocytes (P =.017), -41% and 23% for CD11b-po
sitive monocytes (P =.001), and 7% and 25% for CD62-positive platelets (P =
.041). At 75 minutes of reperfusion, the levels were 15% and -7% for tumor
necrosis factor alpha (P =.025) and -10% and 10% for CD62-positive platelet
s (P = .041), Conclusions: Transcardiac production of proinflammatory cytok
ines is reduced in patients undergoing coronary artery bypass grafting trea
ted with the nitric oxide donor sodium nitroprusside. At the same time, les
s activated leukocytes and platelets are retained in the coronary circulati
on.